PUNE, India, February 23, 2018 /PRNewswire/ --
According to a new market research report "Thyroid
Function Test Market by Type (TSH Tests, T4 Tests, T3 Tests), End
User (Hospitals, Diagnostic Laboratories, Research Laboratories
& Institutes), and Region (North
America, Europe, APAC,
LATAM, and MEA) - Global Forecast to 2022",
published by MarketsandMarkets™, the market is expected to reach
USD 1.68 Billion by 2022 from an
estimated USD 1.26 Billion in 2017,
at a CAGR of 5.9%. Factors such as increasing incidence of thyroid
disorders, awareness about thyroid disorders, prevalence of
lifestyle diseases, rising geriatric population, and increasing
consumption of alcohol and tobacco are driving the growth of the
market.
(Logo:
http://photos.prnewswire.com/prnh/20160303/792302 )
Browse 65 tables and 31 figures spread through 120 pages and
in-depth TOC on "Thyroid Function Test
Market"
https://www.marketsandmarkets.com/Market-Reports/thyroid-function-test-market-85085049.html
Early buyers will receive 10% customization on
this report
By type, the TSH tests segment is expected to account for the
largest share of the market in 2017
On the basis of type, the market is segmented into TSH tests, T4
tests, T3 tests, and other tests. In 2017, the TSH tests segment is
estimated to account for the largest share of the Thyroid Function
Tests Market. The large share rate of this segment can be
attributed to the fact that TSH tests are initially prescribed by
physicians to majority of patients (for the assessment of thyroid
gland functioning) showing symptoms of thyroid disorders.
Inquiry Before Buying:
https://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=85085049
By end user, the hospitals segment is expected to account for
the largest share of the market in 2017
Based on end users, the global Thyroid Function Tests Market is
broadly segmented into hospitals, diagnostic laboratories, research
laboratories and institutes, and other end users. The hospitals
segment is estimated to account for the largest share of the global
Thyroid Function Tests Market in 2017. The large share of the
segment can be attributed to the growing patient population &
the subsequent increase in clinical tests performed in hospitals
and growing number of public healthcare awareness campaigns
organized by hospitals.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownload.asp?id=85085049
North America is estimated
to dominate the market in 2017
In 2017, North America is
expected to account for the largest share of the global Thyroid
Function Tests Market. This large share can be attributed to
factors such as the high prevalence of thyroid disorders in the
region, rising geriatric population, and increasing initiatives by
the Canadian government for healthcare development in the
country.
The prominent players in the global Thyroid Function Tests
Market include Thermo Fisher
(US), Abbott (US), Roche (Switzerland), DiaSorin (Italy), Danaher (US), Kronus (US), Merck
(Germany), Cortez Diagnostics
(US), bioMérieux (France),
Qualigen (US), and Autobio Diagnostics (China).
Browse Related Reports
In Vitro Diagnostics/IVD Market by Product (Instruments,
Reagents, Software), Technology (Immunoassay, Clinical Chemistry,
Molecular Diagnostics, Hematology), Application (Diabetes,
Oncology, Cardiology, Nephrology, Infectious Diseases) - Forecast
to 2021
https://www.marketsandmarkets.com/Market-Reports/ivd-in-vitro-diagnostics-market-703.html
Immunoassay Market by Product & Service (Reagents
& Kits, Analyzers, Software, Services), Technique (ELISA, Rapid
Test), Application (Infectious Diseases, Endocrinology, Oncology),
End User (Clinical Labs, Hospitals) - Global Forecast to 2021
https://www.marketsandmarkets.com/Market-Reports/immunoassay-market-436.html
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000
high growth niche opportunities/threats which will impact 70% to
80% of worldwide companies' revenues. Currently servicing 5000
customers worldwide including 80% of global Fortune 1000 companies
as clients. Almost 75,000 top officers across eight industries
worldwide approach MarketsandMarkets™ for their painpoints around
revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are
tracking global high growth markets following the "Growth
Engagement Model - GEM". The GEM aims at proactive collaboration
with the clients to identify new opportunities, identify most
important customers, write "Attack, avoid and defend" strategies,
identify sources of incremental revenues for both the company and
its competitors. MarketsandMarkets™ now coming up with 1,500
MicroQuadrants (Positioning top players across leaders, emerging
companies, innovators, strategic players) annually in high growth
emerging segments. MarketsandMarkets™ is determined to benefit more
than 10,000 companies this year for their revenue planning and help
them take their innovations/disruptions early to the market by
providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market
research platform, "RT" connects over 200,000 markets and entire
value chains for deeper understanding of the unmet insights along
with market sizing and forecasts of niche markets.
Contact:
Mr. Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Connect with us on LinkedIn
@ http://www.linkedin.com/company/marketsandmarkets
SOURCE MarketsandMarkets